Metagenomi, Inc. (NASDAQ: MGX) had its price target lowered by analysts at Wells Fargo & Company from $25.00 to $20.00. They now have an "overweight" rating on the stock.
HighReport
Metagenomi, Inc. (NASDAQ: MGX) had its price target lowered by analysts at Wells Fargo & Company from $25.00 to $20.00. They now have an "overweight" rating on the stock.
Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems
MediumReport
Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: